Merck, Patient Seek Separate JMOL In Fosamax Trial
Pharmaceutical giant Merck & Co. Inc. has asked a federal judge to dismiss the remaining claims in a product liability and personal injury case over its osteoporosis drug Fosamax, while the...To view the full article, register now.
Already a subscriber? Click here to view full article